BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32933758)

  • 1. Diet and gut microbiome interactions in gynecologic cancer.
    AlHilli MM; Bae-Jump V
    Gynecol Oncol; 2020 Nov; 159(2):299-308. PubMed ID: 32933758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
    McKenzie ND; Hong H; Ahmad S; Holloway RW
    Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment.
    Chase D; Goulder A; Zenhausern F; Monk B; Herbst-Kralovetz M
    Gynecol Oncol; 2015 Jul; 138(1):190-200. PubMed ID: 25957158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.
    Chambers LM; Bussies P; Vargas R; Esakov E; Tewari S; Reizes O; Michener C
    Curr Oncol Rep; 2021 Jun; 23(8):92. PubMed ID: 34125319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiome and gynaecological cancer development, prevention and therapy.
    Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM
    Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the power within: engineering the microbiome for enhanced gynecologic health.
    Brennan C; Chan K; Kumar T; Maissy E; Brubaker L; Dothard MI; Gilbert JA; Gilbert KE; Lewis AL; Thackray VG; Zarrinpar A; Knight R
    Reprod Fertil; 2024 Apr; 5(2):. PubMed ID: 38513356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross talk between drug-resistant epilepsy and the gut microbiome.
    Holmes M; Flaminio Z; Vardhan M; Xu F; Li X; Devinsky O; Saxena D
    Epilepsia; 2020 Dec; 61(12):2619-2628. PubMed ID: 33140419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review.
    Barandouzi ZA; Rowcliffe C; Schrogin J; Meador R; Bruner DW
    Support Care Cancer; 2022 Aug; 30(8):6497-6513. PubMed ID: 35396962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrition, the gut microbiome and the metabolic syndrome.
    Kovatcheva-Datchary P; Arora T
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):59-72. PubMed ID: 23768553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health.
    Donovan SM
    Gut Microbes; 2017 Mar; 8(2):75-81. PubMed ID: 28282253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microbiome and gynecologic cancer: cellular mechanisms and clinical applications.
    Chalif J; Wang H; Spakowicz D; Quick A; Arthur EK; O'Malley D; Chambers LM
    Int J Gynecol Cancer; 2023 Dec; ():. PubMed ID: 38088183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
    Lim YY; Lee YS; Ooi DSQ
    Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Nutrition and the Microbiome, Part I: Current State of the Science.
    Mills S; Stanton C; Lane JA; Smith GJ; Ross RP
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 31022973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome.
    Maier TV; Lucio M; Lee LH; VerBerkmoes NC; Brislawn CJ; Bernhardt J; Lamendella R; McDermott JE; Bergeron N; Heinzmann SS; Morton JT; González A; Ackermann G; Knight R; Riedel K; Krauss RM; Schmitt-Kopplin P; Jansson JK
    mBio; 2017 Oct; 8(5):. PubMed ID: 29042495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaping functional gut microbiota using dietary bioactives to reduce colon cancer risk.
    Seidel DV; Azcárate-Peril MA; Chapkin RS; Turner ND
    Semin Cancer Biol; 2017 Oct; 46():191-204. PubMed ID: 28676459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.
    Tözün N; Vardareli E
    J Clin Gastroenterol; 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015():S191-S196. PubMed ID: 27741173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Applications of the Gut Microbiome in Genitourinary Cancers.
    Nguyen CB; Vaishampayan UN
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e100041. PubMed ID: 38788173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.